Clinlogix, the Lower Gwynedd-based clinical research service organization, is helping companies bring new therapies and therapeutics to market quickly and safely by using innovative tools like blockchain, writes Queen Muse for the Philadelphia Magazine.

The organization, founded by JeanMarie Markham in 1999, helps companies conduct complex, next-generation research to achieve success in health and medicine.

It aids companies in developing everything from new medical devices to pharmaceutical products to emerging technologies.

Clinlogix provides project management and expertise throughout the process, from pre-clinical development to post-market surveillance.

Clinlogix has quickly grown from its original home in the basement of Markham’s Oreland home into a multinational company headquartered at Spring House Innovation Park with regional offices on three continents.

Over the last two decades, the company has supported approximately 500 trials at 3,500 clinical sites worldwide.

It is also the first company to implement a blockchain platform for clinical trials thanks to its partnership with ALTEN Calsoft Labs.

“I’m very excited to be one of the first, if not the first, CRO who is moving ahead with the rapid development and deployment of a blockchain-based platform which will become an industry standard,” said Markham.

[uam_ad id=”64837″]